Syndax Pharmaceuticals
Price & Volume
Stats
See moreOpen | $17.55 |
Previous Close | $17.73 |
Day Range | $16.85-$17.78 |
52W Range | $8.58-$17.87 |
Market Cap | $1.3B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $111.3M |
Revenue Growth (YoY) | 267% |
Gross Profit (12 Mos) | -$133.2M |
Diluted EPS | -$3.60 |
News
See moreYahoo Finance • 7 days ago
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 9 days ago
Syndax Announces Compelling Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Data Accepted for Presentation at ASH 2025
Yahoo Finance • 9 days ago
Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025
Yahoo Finance • 10 days ago
Syndax Pharmaceuticals Q3 2025 Earnings Preview
About
CEO | Mr. Michael A. Metzger M.B.A. |
CFO | Mr. Keith Alan Goldan CPA |
Address | 730 Third Avenue, New York, NY, United States, 10017 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 270 |
